GAM Holding’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-205,800
| Closed | -$3.7M | – | 371 |
|
|
2020
Q2 | $3.7M | Buy |
205,800
+70,800
| +52% | +$985K | 0.23% | 131 |
|
|
2020
Q1 | $963K | Hold |
135,000
| – | – | 0.07% | 233 |
|
|
2019
Q4 | $3.22M | Hold |
135,000
| – | – | 0.15% | 182 |
|
|
2019
Q3 | $3.62M | Hold |
135,000
| – | – | 0.16% | 152 |
|
|
2019
Q2 | $3.66M | Hold |
135,000
| – | – | 0.14% | 160 |
|
|
2019
Q1 | $4.68M | Hold |
135,000
| – | – | 0.2% | 126 |
|
|
2018
Q4 | $2.63M | Sell |
135,000
-16,600
| -11% | -$341K | 0.13% | 182 |
|
|
2018
Q3 | $4.04M | Hold |
151,600
| – | – | 0.15% | 168 |
|
|
2018
Q2 | $5.73M | Hold |
151,600
| – | – | 0.2% | 134 |
|
|
2018
Q1 | $4.95M | Hold |
151,600
| – | – | 0.17% | 152 |
|
|
2017
Q4 | $7.38M | Hold |
151,600
| – | – | 0.23% | 118 |
|
|
2017
Q3 | $8.19M | Hold |
151,600
| – | – | 0.35% | 81 |
|
|
2017
Q2 | $8.52M | Hold |
151,600
| – | – | 0.13% | 208 |
|
|
2017
Q1 | $5.94M | Sell |
151,600
-57,500
| -27% | -$1.83M | 0.09% | 262 |
|
|
2016
Q4 | $4.69M | Hold |
209,100
| – | – | 0.08% | 273 |
|
|
2016
Q3 | $4.75M | Sell |
209,100
-249,125
| -54% | -$5.85M | 0.08% | 275 |
|
|
2016
Q2 | $10.8M | Buy |
458,225
+207,089
| +82% | +$5.11M | 0.17% | 151 |
|
|
2016
Q1 | $5.12M | Buy |
251,136
+67,467
| +37% | +$2.14M | 0.09% | 262 |
|
|
2015
Q4 | $9.45M | Sell |
183,669
-29,124
| -14% | -$1.41M | 0.15% | 173 |
|
|
2015
Q3 | $9.07M | Buy |
212,793
+22,714
| +12% | +$1.1M | 0.16% | 168 |
|
|
2015
Q2 | $8.66M | Buy |
+190,079
| New | +$7.65M | 0.13% | 192 |
|
GAM Holding's PTLA Position: Q3 2020 in Review
GAM Holding sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 205,800 shares — an estimated $3.7M sold.
GAM Holding first reported a position in PTLA in Q2 2015 and held it in 21 quarters. The position peaked at $10.8M in Q2 2016. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- GAM Holding reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- GAM Holding sold 205,800 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.7M.
- GAM Holding first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and held it in 21 quarters.
- GAM Holding's Portola Pharmaceuticals, Inc. position peaked at $10.8M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on GAM Holding's 13F filing for Q3 2020, filed 6 Nov 2020.